Posted inBiotechnology
Galaxamide protects mouse uterus from cisplatin injury via anti-inflammatory effects
A sea-derived molecule best known as a potential anticancer agent may also shield the uterus from one of chemotherapy’s most…
Posted inBiotechnology
Moving NAMs from Progress to Practice: Building the Foundation for Broader Adoption
The future of NAMs depends on more than innovation. Learn how sourcing, standards and evidence can accelerate adoption.
Posted inBiotechnology
Luma locks down 15-year, $410M fund for life science investments
Luma Group announced the final close of its inaugural life sciences venture capital fund totaling $410 million.
Posted inBiotechnology
GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing
Neuro-focused Encoded Therapeutics has bagged a $275 million series F round to support its Dravet syndrome asset and scale up…
Posted inBiotechnology
Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock
Tyra Biosciences has reported initial phase 2 data on dabogratinib in bladder cancer, putting the biotech on course to start…
Posted inBiotechnology
Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapy
Kura Oncology has spun out a biotech armed with $50 million in fresh funding to take forward a next-generation diabetes…
Posted inBiotechnology
Silicon’s complex effects on arsenic in rice shaped by terrain and soil
Rice, the staple crop that feeds more than half of humanity, has a persistent and well-documented problem: it accumulates arsenic…
Posted inBiotechnology
Cobimetinib boosts calreticulin and reshapes immunity in triple-negative breast cancer
In a finding that could reshape how researchers think about pairing targeted cancer drugs with immunotherapy, a team based at…
Posted inBiotechnology
Dual radioligand therapy targets neuroendocrine bone metastases in pilot study
When cancer spreads to bone from a neuroendocrine tumor, patients face a double burden: the tumor itself keeps growing, and…
Posted inBiotechnology
VMA21 loss disrupts autophagy and vesicle trafficking in X-linked myopathy
In a significant advance for understanding a rare and devastating muscle disease, researchers at Washington University School of Medicine in…